IVF INVO Fertility, Inc.
Price Chart
Executive Summary
INVO Fertility reported FY2025 revenue of $6.84M (+5% YoY) and a net loss from continuing operations of $(5.3)M, improved from $(7.7)M in FY2024. The company highlighted a strengthened balance sheet with $11.5M in recent financing, the acquisition of Family Beginnings, and the elimination of Series C-2 Preferred and warrant liabilities. However, Adjusted EBITDA worsened to $(3.2)M from $(2.2)M, and the net loss attributable to common shareholders was $(25.1)M due to discontinued operations and warrant deemed dividends.
Actionable Insight
The filing shows a mixed picture: improving revenue and narrowing operating loss from continuing operations, but a worsening Adjusted EBITDA and a massive net loss from discontinued operations. The balance sheet strengthening and acquisition provide a positive narrative, but the company remains deeply unprofitable with a $2M market cap. Monitor for the next quarterly filing to see if organic growth initiatives and the Family Beginnings acquisition translate into improving cash flows.
Key Facts
- FY2025 revenue of $6,841,250, up 5% from $6,532,000 in FY2024.
- Net loss from continuing operations improved to $(5.3)M from $(7.7)M.
- Adjusted EBITDA worsened to $(3.2)M from $(2.2)M.
- Closed acquisition of Family Beginnings in February 2026, adding ~$1.2M in trailing revenue.
- Raised $11.5M in gross proceeds from December 2025 and January 2026 financings.
- All Series C-2 Preferred converted or retired; warrant liabilities eliminated.
- Net loss attributable to common shareholders was $(25.1)M, including $(16.5)M from discontinued operations and $(1.8)M in warrant deemed dividends.
- Weighted average basic shares outstanding: 117,083 in FY2025 vs 2,514 in FY2024.
Financial Impact
Revenue growth of 5% to $6.84M; net loss from continuing ops improved by ~31% to $(5.3)M; Adjusted EBITDA declined by 41% to $(3.2)M.
Risk Factors
- Continued operating losses and negative Adjusted EBITDA.
- Massive net loss from discontinued operations ($16.5M) and warrant deemed dividends ($1.8M).
- Extremely low market cap ($2M) and thin trading liquidity.
- Dependence on future acquisitions and financing for growth.
Market Snapshot
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-026777 |
| Document: form8-k.htm | 0001493152-26-026777 |
| Document: 0001493152-26-026777-index-headers.html | 0001493152-26-026777 |
| Document: 0001493152-26-026777-index.html | 0001493152-26-026777 |
| Document: 0001493152-26-026777.txt | 0001493152-26-026777 |
| 8-K Data (Synthetic) | 0001493152-26-026777 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 2, 2026
12d ago
|
Press Release
| $1.70 $1.66 | ▲ +2.35% | ▲ +2.75% | $1.48 (+12.94%) |
|
Jun 2, 2026
12d ago
|
8-K
| $1.52 $1.70 | ▲ +11.84% | ▲ +12.54% | $1.48 (−2.63%) |
|
Jun 2, 2026
12d ago
|
8-K
| $1.52 $1.70 | ▼ −11.84% | ▼ −12.54% | $1.48 (+2.63%) |
|
Jun 2, 2026
12d ago
|
Press Release
| $1.52 $1.70 | ▲ +11.84% | ▲ +12.54% | $1.48 (−2.63%) |
|
Mar 3, 2026
14w ago
|
Press Release
| $4.33 $4.44 | ▲ +2.54% | ▲ +1.78% | $1.48 (−65.78%) |
|
Feb 24, 2026
15w ago
|
8-K
| $5.00 $4.97 | ▼ −0.50% | ▼ −1.33% | $1.48 (−70.37%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access